on 29 Apr 2004
Last Applicant/ Owned by
AETERNA ZENTARIS INC.
1405 boul. du Parc - Technologique
Quebec, , G1P 4P5
Serial Number
UK00903805413 filed on 29th Apr 2004
Registration Number
UK00903805413 registered on
8th Sept 2005
Correspondent Information
AA Thornton IP LLP
8th Floor, 125 Old Broad Street
London,
EC2N 1AR
Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of haematological diseases, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparations used for the treatment of ophtalmological disorders, pharmaceutical preparations used for the treatment of reproductive system disorders, pharmaceutical preparations used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparations used for the treatment of benign prostatic hyperplasia (BPH), pharmaceutical preparations used for the treatment of tropical diseases, pharmaceutical preparations used for the treatment of infectious disease, pharmaceutical preparations used for the treatment of leishmaniasis, pharmaceutical preparations used for the treatment of obesity, pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes, pharmaceutical preparations containing cytotoxic products (conjugated or not), pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on bombesin antagonist platform, pharmaceutical preparations based on inhibitors of the Akt pathway, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis, pharmaceutical preparations used to stimulate growth hormone secretagogue (GHS).
UK00903805413
Word
Individual